Fewer than 5,000 people prescribed anticholesterol drug inclisiran in primary care as of July 2023 Exclusive: Despite NHS England’s target for 300,000 patients to be using inclisiran by October 2024, 4,549 people had been prescribed it in primary care between October 2021 and July 2023.…
